Ambros Therapeutics is based in Irvine, California. It has raised $125M in total funding. Latest round: Series A.
Ambros Therapeutics is based in Irvine, California. Ambros Therapeutics has raised $125M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in December 2025. The round record for Ambros Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include RA Capital Management, Enavate Sciences, Patient Square Capital, Abiogen Pharma, Janus Henderson Investors, Arkin Bio and 3 others. 9 distinct backers are named across the disclosed rounds.
Round data for Ambros Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Irvine and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026